Article of the Month:
Routine cerebral embolic protection (CEP) during TAVI - The BHF PROTECT-TAVI Trial.
This study in NEJM enrolled patients from 33 centres in the UK in a 1:1 ratio. Disabling stroke occurred in 1.2% of patients in the CEP arm vs 1.4% in the control arm. Other secondary outcomes including access complications were similar between groups.
Previous Articles of the Month
